This strategy essentially aims to transform DMD into a slower-progressing muscular dystrophy, potentially more like some forms of Becker muscular dystrophy (BMD), a disease caused by dystrophin mutations that create in-frame transcripts resulting in production of a variety of truncated forms of dystrophin that are associated with different rates of disease progression. This evidence concerns the gene DMD and muscular dystrophy.